Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Protalix Biotherapeutics (PLX)

0.447 0.019 (4.49%)

05-25 15:59

Open:

0.44

Pre. Close:

0.4278

High:

0.4799

Low:

0.4338

Volume:

833,075

Market Cap:

65M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.481 - 0.483

0.483 - 0.484

Low:

0.426 - 0.428

0.428 - 0.429

Close:

0.447 - 0.45

0.45 - 0.453

Technical analysis  (as of: 2018-05-25 4:38:14 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.56     One year: 0.65

Support:

Support1: 0.42    Support2: 0.39

Resistance:

Resistance1: 0.48    Resistance2: 0.56

Pivot:

0.43

Moving Averages:

MA(5): 0.44     MA(20): 0.42

MA(100): 0.57     MA(250): 0.64

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 50.74     %D(3): 49.01

RSI:

RSI(14): 52.81

52-Week:

High: 0.99  Low: 0.39  Change(%): -49.8

Average Vol(K):

3-Month: 66244  10-Days 31873

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PLX has closed below upper band by 19.5%. Bollinger Bands are 38.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-15T09:11:53-04:00
How De-Risked Is Protalix's Fabry Superiority Trial?

2018-05-10T17:17:45-04:00
Protalix: Valuable, Misunderstood, And Deeply Mispriced

2018-05-09T10:14:03-04:00
Protalix BioTherapeutics' (PLX) CEO Moshe Manor on Q1 2018 Results - Earnings Call Transcript

2018-05-09T08:14:47-04:00
Protalix Q1 revenues up 59%

2018-05-09T07:03:46-04:00
Protalix BioTherapeutics beats by $0.03, beats on revenue

2018-04-15T03:05:31-04:00
Rounds Report: Nephros And Protalix Bulls Charged Ahead While Crispr Insiders Built Shares

2018-04-15T00:25:16-04:00
Portfolio Review: Continued Market Outperformance In Q1 2018

2018-04-09T03:46:20-04:00
BioSci Research On Myovant Sciences (Part I): Is This A Big Winner In The Making?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

145.57

Shares Float (M)

141.17

% Held by Insiders

3.00

% Held by Institutions

10.40

Shares Short (K)

5333

Shares Short Prior Month (K)

Stock Financials

EPS

-0.310

EPS Est. Current Year

-0.180

EPS Est. Next Year

-0.110

EPS Est. Next Quarter

-0.010

Forward EPS

0.190

Book Value (p.s.)

24.330

PEG Ratio

-0.08

Profit Margin

Operating Margin

-178.42

Return on Assets (ttm)

-110.4

Return on Equity (ttm)

413.5

Qtrly Rev. Growth

57.6

Gross Profit (p.s.)

0.016

Sales Per Share

EBITDA (p.s.)

-0.023

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.98

Levered Free Cash Flow (M)

-26.48

atoplab.com

Valuation

P/E

-1.44

P/E Growth Ratio

0.04

P/BV

0.02

P/S

433798592.00

P/CF

-5.93

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.